PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories.
Pepe F, Venetis K, Cursano G, Frascarelli C, Pisapia P, Vacirca D, Scimone C, Rappa A, Russo G, Mane E, Pagni F, Castellano I, Troncone G, Angelis C, Curigliano G, Guerini-Rocco E, Malapelle U, Fusco N.
Pepe F, et al. Among authors: troncone g.
Pharmacogenomics. 2024 Feb;25(3):161-169. doi: 10.2217/pgs-2023-0238. Epub 2024 Mar 5.
Pharmacogenomics. 2024.
PMID: 38440825